Patent details

EP3247394 Title: PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODY

Basic Information

Publication number:
EP3247394
PCT Application Number:
KR2016000472
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167403567
PCT Publication Number:
WO2016117883
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODY
French Title of Invention:
FORMULATION PHARMACEUTIQUE COMPRENANT DES ANTICORPS ANTI-EGFR
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNG MIT ANTI-EGFR-ANTIKÖRPER
SPC Number:

Dates

Filing date:
15/01/2016
Grant date:
12/05/2021
EP Publication Date:
29/11/2017
PCT Publication Date:
28/07/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/05/2021
EP B1 Publication Date:
12/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/01/2022
Expiration date:
15/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/05/2021
 
 

Name:
Green Cross Corporation
Address:
107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do 16924, Korea (Republic) (KR)

Inventor

1

Name:
CHOI, Yong Woon
Address:
Korea (Republic) (KR)

2

Name:
CHOI, Jungsub
Address:
Korea (Republic) (KR)

3

Name:
KIM, Yoo Hoon
Address:
Korea (Republic) (KR)

Priority

Priority Number:
20150008677
Priority Date:
19/01/2015
Priority Country:
Korea (Republic) (KR)

Classification

IPC classification:
A61K 39/395; C07K 16/28; A61K 47/34;

Publication

European Patent Bulletin

Issue number:
202119
Publication date:
12/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages